A paradigm shift in the role of NSAIDs in COVID-19: new pathological mechanisms and potential treatment targets

• Authors: Petre Cristian Ilie , Simina Stefanescu , Nicola Veronese

Abstracts

EN

Objectives: The pathogeny of SARS-COV2 infection is currently not well defined. In this paper, we present a new perspective of how the SARS-CoV2 infection can lead to severe cases and potential pathways of preventing such cases. Methods: In the first part, we describe the role of cyclooxigenase 2 and in the second part, we describe the role of hypoxia inducible factor (HIF). Findings: We hypothesize that cyclooxigenase 2 and hypoxia inducible factor with subsequent inflammation and hypoxia can up-regulate each other in a vicious circle of feed-forward that can ultimately lead to “cytokine storm”. Conclusions: Breaking this cycle early potentially will have beneficial effects either by improving oxygenation (oxygen being given earlier in the course of the treatment) or by inhibiting COX-2. We also believe, that the use of COX-2 inhibitors early in the course of the disease can improve the outcome and clinical trial are urgently needed. 

Keywords

EN

Paradigm Shift; NSAIDs; Covid-19; COX-2 inhibitors

• Publisher: Atena Research Association
• Journal: Atena Journal of Public Health
• Year: 2020
• Volume: 2
• Pages: 6-6

Dates

published

2020

Contributors

author

Petre Cristian Ilie

author

Simina Stefanescu

author

Nicola Veronese

References

• Raaben M, Einerhand AW, Taminiau LJ, et al. Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection. Virol J. 2007;4(55):1-5. https://doi.org/10.1186/1743-422X-4-55
• Amici C, Di Caro A, Ciucci A, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11(8):1021-1030.
• Abecassis M, Falk J, Dindzans V, et al. Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible Balb/cJ mice. Adv Exp Med Biol. 1987;218:465-466. https://doi.org/10.1007/978-1-4684-1280-2_58
• Macphee PJ, Dindzans VJ, Fung LS, Levy GA. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology. 1985;5(4):649-660. https://doi.org/10.1002/hep.1840050422
• Cole EH, Schulman J, Urowitz M, Keystone E, Williams C, Levy GA. Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. J. Clin. Invest. 1985;75(3):861-868. https://doi.org/10.1172/JCI111784
• Gaspar JM, Velloso LA. Hypoxia inducible factor as a central regulator of metabolism–implications for the development of obesity. Front. Neurosci. 2018;12:813. https://doi.org/10.3389/fnins.2018.00813
• Yeo EJ. Hypoxia and aging. Exp Mol Med. 2019;20;51(6):1-15. https://doi.org/10.1038/s12276-019-0233-3
• D’Ignazio L, Bandarra D, Rocha S. NF-?B and HIF crosstalk in immune responses. FEBS J. 2016;283(3):413-424. https://doi.org/10.1111/febs.13578
• Ren L, Zhang W, Han P, et al. Influenza A virus (H1N1) triggers a hypoxic response by stabilizing hypoxia-inducible factor-1? via inhibition of proteasome. Virology. 2019;530:51-58. https://doi.org/10.1016/j.virol.2019.02.010
• Kaidi A, Qualtrough D, Williams AC, Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 2006;66(13):6683-6691. https://doi.org/10.1158/0008-5472.CAN-06-0425
• Csiki I, Yanagisawa K, Haruki N, et al. Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1? in non-small cell lung cancer. Cancer Res 2006;66:143–150. https://doi.org/10.1158/0008-5472.CAN-05-1357
• Sander WJ, O'Neill HG, Pohl CH. Prostaglandin E2 as a Modulator of Viral Infections. Frontiers in Physiology. 2017;8:89. https://doi.org/10.3389/fphys.2017.00089
• Lebedeva ES, Kuzubova NN, Titova ON, Surkova EA. Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model. Eur Resp J. 2017;50: PA3926. https://doi.org/10.1183/1393003.congress-2017.PA3926
• Kotzé-Hörstmann LM, Keswell D, Adams K, Dlamini T, Goedecke JH. Hypoxia and extra-cellular matrix gene expression in adipose tissue associates with reduced insulin sensitivity in black South African women. Endocrine. 2017;55:144–152. https://doi.org/10.1007/s12020-016-1089-0
• Ribeiro AL, Correia J, Ribeiro V. Ethnic variability of HIF-1alpha polymorphisms. Cancer Biomark. 2009;5(6):273-277. https://doi.org/10.3233/CBM-2009-0112
• Brasky TM, Bonner MR, Moysich KB, et al. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2011;126:157–165. https://doi.org/10.1007/s10549-010-1082-xhttps://doi.org/10.1007/s10549-010-1082-x
• Chan PC, Liao MT, Hsieh PS. The Dualistic Effect of COX-2-Mediated Signaling in Obesity and Insulin Resistance. Int J Mol Sci. 2019;20(13):3115. https://doi.org/10.3390/ijms20133115
• Chan PC, Hsiao FC, Chang HM, Wabitsch M, Hsieh PS. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance. FASEB J.2016;30(6):2282-2297. https://doi.org/10.1096/fj.201500127
• Xu K, Sun X, Benderro GF, Tsipis CP, LaManna JC. Gender differences in hypoxic acclimatization in cyclooxygenase-2-deficient mice. Physiol Rep. 2017;5(4). https://doi.org/10.14814/phy2.13148
• Cosentione F, Eto M, De Paolis P, et al. High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells. Role of Protein Kinase C and Reactive Oxygen Species. Circulation. 2003;107:1017–1023. https://doi.org/10.1161/01.CIR.0000051367.92927.07
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–1761. https://doi.org/10.1172/JCI21625
• Huang W, Lin S, Chen H, et al. NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation. J Neuroinflammation. 2018;15(140):1-15. https://doi.org/10.1186/s12974-018-1186-5
• Wang W, Suzuki Y, Tanigaki T, Rank DR, Raffin TA. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am J Respir Crit Care Med. 1994;150(5):1449-1452. https://doi.org/10.1164/ajrccm.150.5.7952574
• Bradshaw PC. Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging. Nutrients. 2019;11(3):504. https://doi.org/10.3390/nu11030504
• Gomes AP, Price NL, Ling AJY. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. 2013;155(7):1624-1638. https://doi.org/10.1016/j.cell.2013.11.037

Identifiers

Biblioteka Nauki

1491092